| Weight | 0,05 kg |
|---|
Retatrutide + Cagrilintide 10mg
Research Grade Peptide
- Research Grade
- 99% Purity
- Third-Party Verified
Reference Strength: 10mg
R1299,00
Availability: In stock
SKU: RC10
R1299,00
A fixed-ratio research blend combining Cagrilintide, a long-acting amylin receptor agonist, with Retatrutide, a triple GLP-1/GIP/glucagon receptor agonist.
Availability: In stock
Included with your purchase
Each qualifying product includes 3ml of 0.9% Benzyl Alcohol Bacteriostatic Water.
Complimentary Purchase Kit
Every qualifying vial includes a complimentary purchase kit at no additional cost.
Research Overview
About Retatrutide + Cagrilintide 10mg
The blend combines complementary mechanisms: Cagrilintide enhances satiety and slows gastric emptying, while Retatrutide acts through three metabolic hormone receptors.
How It Works in Research
The blend combines complementary mechanisms: Cagrilintide enhances satiety and slows gastric emptying, while Retatrutide acts through three metabolic hormone receptors.
Research Applications
• Body-weight management • Appetite regulation • Satiety • Metabolic health • Energy expenditure • Glucose regulation
Researchers investigate this blend because it combines two different metabolic pathways that may work together to improve appetite control and energy balance.
Product Specifications
- Researchers investigate this blend because it combines two different metabolic pathways that may work together to improve appetite control and energy balance.
Research Information
- Category: Metabolic peptide blend
- Reconstitution: 2.0 mL bacteriostatic water
- Final Concentration: 5 mg/mL total blend
- Storage: 2–8°C after reconstitution
Mechanism of Action
Cagrilintide mimics the hormone amylin, promoting satiety and delaying gastric emptying. Retatrutide activates GLP-1, GIP and glucagon receptors, influencing appetite, glucose metabolism and energy expenditure. Researchers investigate whether combining these complementary pathways provides additive metabolic effects.
Key Research Characteristics
Fixed-ratio peptide blend
Once-weekly research framework Metabolic research Appetite regulation Weight-management research
Potential Benefits in Research
May support appetite regulation.
- May promote satiety and reduced caloric intake.
- May support body-weight management in research settings.
- May improve metabolic regulation through complementary mechanisms.
- May enhance energy expenditure via triple receptor agonism.
Safety Profile
Gastrointestinal symptoms such as nausea, vomiting or reduced appetite may occur.
- Dose escalation is commonly used in research to improve tolerability.
Research Applications
Body-weight management
Appetite regulation
Satiety
Metabolic health
Energy expenditure
Glucose regulation
This is an educational research framework and not an established clinical dosing protocol.
REFERENCE RECONSTITUTION INFORMATION
Goal: Support research into appetite regulation and metabolic health. Schedule: Once weekly. Cycle Length: 16–24 weeks. Reconstitution: Add 2.0 mL bacteriostatic water to one 5 mg + 5 mg vial.
Always follow sterile preparation techniques when handling research peptides.
This is an educational research framework and not an established clinical dosing protocol.
General Preparation
• This is an educational research framework and not an established clinical dosing protocol. • Maintain the fixed 1:1 ratio throughout dosing. • Use a new sterile syringe for each injection. • Store refrigerated after reconstitution.
- Slowly add 2.0 mL bacteriostatic water down the inside wall of the vial. Allow the powder to dissolve naturally. Gently swirl until clear; do not shake.
RETATRUTIDE + CAGRILNITIDE (10MG)- RECONSTITUTION TABLES
Reference Handling Information
Reference information for laboratory handling of Retatrutide + Cagrilintide 10mg.
- Schedule: Once weekly.
- Cycle Length: 16–24 weeks.
- After reconstitution, the total blend concentration is approximately 5 mg/mL. Each U-100 unit (0.01 mL) delivers approximately 0.05 mg of the total blend (0.025 mg Cagrilintide + 0.025 mg Retatrutide).
- Before Reconstitution: Store lyophilised vial at −20°C. After Reconstitution: Refrigerate at 2–8°C. Avoid freeze–thaw cycles.
Reference Parameters (Dosing Protocol)
| Week | Total Blend Dose | U-100 Units | Volume |
|---|---|---|---|
| Weeks 1–2 | 0.5 mg total (0.25 mg + 0.25 mg) | 10 units | 0.10 mL |
| Weeks 3–4 | 1.0 mg total (0.5 mg + 0.5 mg) | 20 units | 0.20 mL |
| Weeks 5–8 | 1.5 mg total (0.75 mg + 0.75 mg) | 30 units | 0.30 mL |
| Weeks 9–12 | 2.0 mg total (1.0 mg + 1.0 mg) | 40 units | 0.40 mL |
| Weeks 13–16 | 2.5 mg total (1.25 mg + 1.25 mg) | 50 units | 0.50 mL |
For laboratory research only.
Experimental Study Period
STUDY PERIOD
After reconstitution, the total blend concentration is approximately 5 mg/mL. Each U-100 unit (0.01 mL) delivers approximately 0.05 mg of the total blend (0.025 mg Cagrilintide + 0.025 mg Retatrutide).
RESEARCH CONTEXT
Support research into appetite regulation and metabolic health.
Once weekly.
View Certificate of Analysis
View Certificate of Analysis Each batch of Retatrutide + Cagrilintide is independently tested by third-party laboratories. Download the Certificate of Analysis to verify purity, identity, and quality.
99%
Verified Purity
3rd Party
Lab Tested
Certified
Quality Assured
Related products
-
Metabolic Research
Semaglutide
Price range: R599,00 through R999,00 Select options This product has multiple variants. The options may be chosen on the product page -
Metabolic Research
MOTS-c
Price range: R639,00 through R1199,00 Select options This product has multiple variants. The options may be chosen on the product page
PURE PERFORMANCE LABS
Recommended Research Products
Explore related compounds commonly viewed alongside this product.
FOR RESEARCH PURPOSES ONLY
This product is intended for research and laboratory use only. Always consult qualified researchers and follow appropriate safety protocols.